Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not receive 2nddose of Shingrix yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient got the first shot back on 30 October 2022). The patient did not receive the 2nd dose of Shingrix, the patient experienced incomplete course of vaccination (Verbatim: did not receive 2nddose of Shingrix yet). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 22-JUL-2025 Other HCP reported to get guidance on Shingrix vaccination. He informed that a male elder patient got the first shot back on 30 October 2022 and did not complete the schedule. He wanted to know if the second dose can be administered or if the complete series has to be restarted. Till the time of reporting patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.